AOP Orphan Diseases
Austria - ViennaBiotechnology
Focus: AOP Orphan Diseases is a private biotechnology company headquartered in Vienna, Austria, focused on developing treatments for rare diseases. The company operates in a specialized niche with limited public visibility regarding scale and market position.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Funding Stage
PRIVATE
Open Jobs
2
Should You Work at AOP Orphan Diseases?
AI assessmentAOP Orphan Diseases suits mission-driven scientists willing to tolerate uncertainty in exchange for early-stage impact, but limited transparency and headcount suggest a tightly-held, possibly bootstrap-funded operation with unclear growth trajectory.
Why Work Here
- Early-stage rare disease focus offers opportunity to shape novel therapeutic areas with high unmet medical need and potential for accelerated regulatory pathways.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (2)
Interview Prep Quick Facts
Help build intelligence for AOP Orphan Diseases
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.